BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 23236027)

  • 1. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
    Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
    Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation.
    Amabile N; Azmoun A; Ghostine S; Ramadan R; Haddouche Y; Raoux F; To NT; Troussier X; Nottin R; Caussin C
    Int J Cardiol; 2013 Sep; 168(1):151-6. PubMed ID: 23079085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedural results and 30-day clinical events analysis following Edwards transcatheter aortic valve implantation in 48 consecutive patients: initial experience.
    Zhao QM; Lognone T; Ivascau C; Sabatier R; Roule V; Dahdouh Z; Massetti M; Grollier G
    Chin Med J (Engl); 2012 Aug; 125(16):2807-10. PubMed ID: 22932071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
    Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
    Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).
    Chieffo A; Buchanan GL; Van Mieghem NM; Tchetche D; Dumonteil N; Latib A; van der Boon RM; Vahdat O; Marcheix B; Farah B; Serruys PW; Fajadet J; Carrié D; de Jaegere PP; Colombo A
    J Am Coll Cardiol; 2013 Feb; 61(8):830-6. PubMed ID: 23333140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
    Panchal HB; Ladia V; Amin P; Patel P; Veeranki SP; Albalbissi K; Paul T
    Am J Cardiol; 2014 Dec; 114(12):1882-90. PubMed ID: 25438917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences.
    Gallet R; Seemann A; Yamamoto M; Hayat D; Mouillet G; Monin JL; Gueret P; Couetil JP; Dubois-Randé JL; Teiger E; Lim P
    Am J Cardiol; 2013 Jun; 111(11):1619-24. PubMed ID: 23523059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation.
    Aktug Ö; Dohmen G; Brehmer K; Koos R; Altiok E; Deserno V; Herpertz R; Autschbach R; Marx N; Hoffmann R
    Int J Cardiol; 2012 Sep; 160(1):26-30. PubMed ID: 21458085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation.
    Gasparetto V; Fraccaro C; Tarantini G; Buja P; D'Onofrio A; Yzeiraj E; Pittarello D; Isabella G; Gerosa G; Iliceto S; Napodano M
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):376-83. PubMed ID: 22461314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midterm outcomes after transcatheter aortic valve implantation.
    Lotfi S; Dohmen G; Götzenich A; Haushofer M; Spillner JW; Autschbach R; Hoffmann R
    Innovations (Phila); 2014; 9(5):343-7; discussion 348. PubMed ID: 25238419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions.
    Seiffert M; Schnabel R; Conradi L; Diemert P; Schirmer J; Koschyk D; Linder M; Kersten JF; Grosser A; Wilde S; Blankenberg S; Reichenspurner H; Baldus S; Treede H
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):640-52. PubMed ID: 23172652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves.
    Schwietz T; Behjati S; Gafoor S; Seeger F; Doss M; Sievert H; Zeiher AM; Fichtlscherer S; Lehmann R
    EuroIntervention; 2015 Apr; 10(12):1468-73. PubMed ID: 24970670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transapical aortic valve implantation in patients with previous cardiac surgery.
    Papadopoulos N; Ilioska P; Fichtlscherer S; Lehmann R; Beiras Fernandez A; Moritz A; Doss M; Zierer A
    Ann Thorac Surg; 2014 Jan; 97(1):37-42. PubMed ID: 24075497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency cardiac surgery during transfemoral and transapical transcatheter aortic valve implantation: incidence, reasons, management, and outcome of 411 patients from a single center.
    Griese DP; Reents W; Kerber S; Diegeler A; Babin-Ebell J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E726-33. PubMed ID: 23765631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study.
    Kahlert P; Al-Rashid F; Döttger P; Mori K; Plicht B; Wendt D; Bergmann L; Kottenberg E; Schlamann M; Mummel P; Holle D; Thielmann M; Jakob HG; Konorza T; Heusch G; Erbel R; Eggebrecht H
    Circulation; 2012 Sep; 126(10):1245-55. PubMed ID: 22899774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
    Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
    J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.